CSIMarket
 


Nutriband Inc   (NTRB)
Other Ticker:  
 

Cumulative Nutriband Inc 's Working Capital Ratio for Trailing Twelve Months Period

NTRB's Working Capital Ratio for Trailing Twelve Months Period and Current Assets, Current Liabilities growth


Select the Comparisons : Select the Ratio:

NTRB Working Capital Ratio for Trailing Twelve Months Period

(Oct 31 2022)
III. Quarter
(Jul 31 2022)
I. Quarter
(Apr 30 2022)
I. Quarter
(Oct 31 2021)
III. Quarter
(Jul 31 2021)
II. Quarter
Y / Y Current Liabilities Growth -71.13 % -68.59 % -72.91 % -64.49 % 203.08 %
Y / Y Current Assets Growth 478.03 % 340.29 % 1377.43 % 1740.16 % 571.06 %
Working Capital Ratio for Trailing Twelve Months Period 5.82 3.06 1.81 0.91 0.21
Total Ranking # 798 # 1806 # 2868 # # 3785
Seq. Current Liabilities Growth -3.21 % 13.81 % -23.27 % -65.85 % 5.33 %
Seq. Current Assets Growth -14.75 % -11.37 % -21.97 % 880.39 % -35.06 %


Working Capital Ratio for Trailing Twelve Months Period Comment
On the trailing twelve months basis Nutriband Inc Current Assets average more than doubled by 478.03 % in III. Quarter year on year, while Current Liabilities decreased to $1 millions, this led to increase in in Nutriband Inc 's Working Capital Ratio for Trailing Twelve Months Period to 5.82, Working Capital Ratio for Trailing Twelve Months Period remained below Nutriband Inc average.
Working Capital Ratio for Trailing Twelve Months Period is the average cumulative value over the last four quarters.

Among companies operatig within Biotechnology & Pharmaceuticals industry 119 other companies have achieved higher Working Capital Ratio for Trailing Twelve Months Period than Nutriband Inc . While Working Capital Ratio for Trailing Twelve Months Period overall ranking has improved so far to 798, from total ranking in previous quarter at 1806.

What is Working Capital Ratio?
More about NTRB
Working Capital Ratio NTRB in the most recent quarter
Working Capital Ratio for Trailing Twelve Months Period Company Ranking
Within: No.
Industry # 120
Sector # 462
S&P 500 # 797


Working Capital Ratio for Trailing Twelve Months Period Statistics
High Average Low
5.48 1.22 0.08
(Oct 31 2022)   (Oct 31 2020)




Companies with similar average Working Capital Ratio for Trailing Twelve Months Period for 12 months ending Oct 31 2022, within Biotechnology & Pharmaceuticals Industry Working Capital Ratio for Trailing Twelve Months Period
Pacific Biosciences Of California Inc   15.74 
Forma Therapeutics Holdings Inc.  15.63 
Passage Bio inc   14.54 
Autolus Therapeutics Plc  14.40 
Entera Bio Ltd   14.28 
Candel Therapeutics Inc   14.25 
Ginkgo Bioworks Holdings Inc   13.73 
Solid Biosciences Inc   13.58 
Krystal Biotech Inc   13.25 
Ocugen Inc   13.21 
Omega Therapeutics Inc   13.01 
Curis Inc   12.84 
Inhibikase Therapeutics Inc   12.78 
Exscientia Plc  12.72 
Bionano Genomics Inc   12.57 
Checkmate Pharmaceuticals Inc   12.38 
Tenaya Therapeutics Inc   12.36 
Kodiak Sciences Inc   12.30 
Humacyte Inc   12.14 
Acceleron Pharma inc  12.10 
Allovir Inc   12.00 
Elevation Oncology inc   11.78 
Rapid Micro Biosystems Inc   11.74 
Vaxcyte Inc   11.73 
Kaleido Biosciences Inc   11.73 
Predictive Oncology Inc   11.63 
In8bio Inc   11.55 
Caribou Biosciences Inc   11.49 
Adverum Biotechnologies Inc   11.35 
Allogene Therapeutics Inc   11.32 


Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

BRID's Profile

Stock Price

BRID's Financials

Business Description

Fundamentals

Charts & Quotes

BRID's News

Suppliers

BRID's Competitors

Customers & Markets

Economic Indicators

BRID's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Cryptocurrencies

Sectors & Industries

Commodities

Currencies

News


At a Glance

Stocks

Economy

Industries

Other

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2023 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071